Cisplatin can be administered as an injectable agent both intravenously and as an intra-arterial agent.

**Approved Adult Dosing Regimens**

- Advanced testicular cancer: 20 mg.m^2 IV for a single dose on day 1 of a 21 or 28-day cycle; maximum 100 mg/m^2 per cycle.

- Advanced bladder cancer: 50 to 70 mg.m^2 IV for a single dose on day 1 of a 21 or 28-day cycle; maximum 100 mg/m^2 per cycle.

- Advanced ovarian cancer: 100 mg.m^2 IV for a single dose on day 1 of a 21 or 28-day cycle; maximum 100 mg/m^2 per cycle.

Cisplatin can be used as monotherapy or as part of a multi-drug regimen. Patients should have proper hydration while monitoring urine output before, during, and for 24 hours following administration.

**Renal Dose Adjustments**

- Creatinine clearance between 10 and 50: decrease dose by 25%

- Creatinine clearance below 10: decrease dose by 50%

- Hemodialysis: Decrease the dose by 50% with no supplement; administer after dialysis on dialysis days with no supplement

- Peritoneal dialysis: Decrease the dose by 50% with no supplement